Ontology highlight
ABSTRACT: Background
African American (AA) patients have higher cancer mortality rates and shorter survival times compared to European American (EA) patients. Despite a significant focus on socioeconomic factors, recent findings strongly argue the existence of biological factors driving this disparity. Most of these factors have been described in a cancer-type specific context rather than a pan-cancer setting.Methods
A novel in silico approach based on Gene Set Enrichment Analysis (GSEA) coupled to Transcription Factor enrichment was carried out to identify common biological drivers of pan-cancer racial disparity using The Cancer Genome Atlas (TCGA) dataset. Mitochondrial content in patient tissues was examined using a multi-cancer tissue microarray approach (TMA).Results
Mitochondrial oxidative phosphorylation was uniquely enriched in AA tumors compared to EA tumors across various cancer types. AA tumors also showed strong enrichment for the ERR1-PGC1α-mediated transcriptional program, which has been implicated in mitochondrial biogenesis. TMA analysis revealed that AA cancers harbor significantly more mitochondria compared to their EA counterparts.Conclusions
These findings highlight changes in mitochondria as a common distinguishing feature between AA and EA tumors in a pan-cancer setting, and provide the rationale for the repurposing of mitochondrial inhibitors to treat AA cancers.
SUBMITTER: Piyarathna DWB
PROVIDER: S-EPMC6546480 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature
Piyarathna Danthasinghe Waduge Badrajee DWB Balasubramanian Akhila A Arnold James M JM Lloyd Stacy M SM Karanam Balasubramanyam B Castro Patricia P Ittmann Michael M MM Putluri Nagireddy N Navone Nora N Jones Jeffrey A JA Yu Wendong W Sandulache Vlad C VC Sikora Andrew G AG Michailidis George G Sreekumar Arun A
The Journal of clinical investigation 20190328 6
<h4>Background</h4>African American (AA) patients have higher cancer mortality rates and shorter survival times compared to European American (EA) patients. Despite a significant focus on socioeconomic factors, recent findings strongly argue the existence of biological factors driving this disparity. Most of these factors have been described in a cancer-type specific context rather than a pan-cancer setting.<h4>Methods</h4>A novel in silico approach based on Gene Set Enrichment Analysis (GSEA) c ...[more]